Want to join the conversation?
Drugmaker $ALXN reported a decline in 2Q16 earnings due to higher interest expense and a rise in income tax expense. Net income fell to $114.94MM or $0.51 per share from $170.22MM or $0.83 per share last year. Total revenues grew to $753.12MM from $636.21MM. Non-GAAP EPS decreased to $1.13 from $1.30.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?